Zhan Wang

Central South University - Hunan Cancer Hospital

Changsha, 410013

China

SCHOLARLY PAPERS

3

DOWNLOADS

89

TOTAL CITATIONS

0

Scholarly Papers (3)

1.

Potential Utility of Albumin-Bilirubin (ALBI) and Body Mass Index (BMI)-Based Logistic Model to Predict Survival Outcome in Non-Small Cell Lung Cancer with Liver Metastasis Treated with PD-1 Inhibitor

Number of pages: 52 Posted: 21 Aug 2023
Central South University - Department of Medical Oncology, Qinghai Provincial People's Hospital - Department of Medical Oncology, Central South University - Hunan Cancer Hospital, Shanghai Jiao Tong University (SJTU), Hunan University of Medicine - Department of Medical Oncology, Central South University - Hunan Cancer Hospital, Central South University - Hunan Cancer Hospital, Central South University - Hunan Cancer Hospital, Central South University - Hunan Cancer Hospital, Central South University - Hunan Cancer Hospital, Central South University - Hunan Cancer Hospital, Central South University - Hunan Cancer Hospital, Huazhong University of Science and Technology - Cancer Center, Huazhong University of Science and Technology - Cancer Centre, Central South University - Hunan Cancer Hospital, Central South University - Hunan Cancer Hospital, Huazhong University of Science and Technology - Cancer Centre, Central South University - Hunan Cancer Hospital, Central South University - Hunan Cancer Hospital, Central South University - Hunan Cancer Hospital, Central South University - Hunan Cancer Hospital, Central South University - Hunan Cancer Hospital, Central South University - Department of Medical Oncology, Central South University - Department of Medical Oncology and Central South University - Department of Medical Oncology
Downloads 39 (954,577)

Abstract:

Loading...

albumin-bilirubin grading system, immune checkpoint inhibitor, liver metastasis non-small cell lung cancer, prognostic markers

2.

PD-1 Blockade Plus Chemotherapy for EGFR-Mutant, EGFR Tyrosine Kinase Inhibitor-Pretreated Non-Small Cell Lung Cancer: A Multicenter Retrospective Study on Efficacy and Biomarker Exploration

Number of pages: 66 Posted: 31 May 2022
Central South University - Department of Medical Oncology, Central South University - Department of Medical Oncology, Qinghai Provincial People's Hospital - Department of Medical Oncology, Shanghai Jiao Tong University (SJTU) - Department of Pathology, Hunan University of Medicine - Department of Medical Oncology, Central South University - Hunan Cancer Hospital, Central South University - Hunan Cancer Hospital, Central South University - Hunan Cancer Hospital, Central South University - Hunan Cancer Hospital, Central South University - Hunan Cancer Hospital, Central South University - Hunan Cancer Hospital, Central South University - Hunan Cancer Hospital, Huazhong University of Science and Technology - Cancer Center, Huazhong University of Science and Technology - Cancer Centre, Central South University - Hunan Cancer Hospital, Central South University - Hunan Cancer Hospital, Huazhong University of Science and Technology - Cancer Centre, Central South University - Department of Medical Oncology and Central South University - Department of Medical Oncology
Downloads 36 (984,689)

Abstract:

Loading...

Non-small cell lung cancer, immune checkpoint inhibitor, EGFR, tyrosine kinase inhibitors, lymphocyte subsets model

3.

Sintilimab Plus Docetaxel as Second-Line Therapy of Advanced Non-Small Cell Lung Cancer Without Targetable Mutations: A Phase II Efficacy and Biomarker Study

Number of pages: 28 Posted: 25 Apr 2022
Central South University - Department of Medical Oncology, Central South University - Department of Medical Oncology, Central South University - Department of Medical Oncology, Central South University - Hunan Cancer Hospital, Central South University - Hunan Cancer Hospital, Central South University - Hunan Cancer Hospital, Central South University - Hunan Cancer Hospital, Central South University - Hunan Cancer Hospital, Shanghai Jiao Tong University (SJTU) - State Key Laboratory of Oncogenes and Related Genes, Central South University - Hunan Cancer Hospital, Qinghai Provincial People's Hospital - Department of Medical Oncology and Central South University - Department of Medical Oncology
Downloads 14 (1,242,099)

Abstract:

Loading...

Sintilimab plus docetaxel, NSCLC, CTC-PD-L1, multiplex immunofluorescence